A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult IDH1-wild glioblastomas
Acta Radiologica · 2024
DOI: 10.1177/02841851241265164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Radiologica, 2024. Verfasst von Dongdong Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huashan Hospital, Fudan University, Shanghai, PR China. Hauptthemen laut MEDLINE: Glioblastoma, Isocitrate Dehydrogenase, Brain Neoplasms, ErbB Receptors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Key R&D Program of China, Youth Program of Special Project for Clinical Research of Shanghai Municipal Health Commission Health industry.
Abstract (Originalsprache)
Background
Molecular alteration events are common in glioblastomas, the isocitrate dehydrogenase (IDH)-wild of which have had poor survival results so far. The progress of radiomics-based model provides novel sights for its preoperatively noninvasive prediction.
Purpose
To develop a radiomics-based model for predicting epidermal growth factor receptor (EGFR) amplification status in IDH1-wild glioblastomas of adults by pretreatment diffusion tensor imaging (DTI). Material and Methods A total of 124 patients with diagnosed glioblastomas were retrospectively collected. Six conventional magnetic resonance imaging (MRI) features of all the tumors were evaluated visually. Patients were divided into the training (n = 87) and the test set (n = 37) with a ratio of 7:3. Radiomics features were extracted from two regions of the glioblastomas, which were the total tumor (ROI_1) and the solid portion of tumor (ROI_2). The radiomics features extracted from the DTI and T1–contrast-enhanced (T1C) images were selected using the least absolute shrinkage and selection operator (LASSO) regression algorithm. Logistic regression analysis was conducted to develop models for EGFR amplification prediction in the training set.
Results
The radiomics model based on ROI_1 demonstrated favorable discrimination in both the training (area under the curve [AUC] = 0.86) and the test set (AUC = 0.82) ( P < 0.05). Combining the radiomics features and the conventional feature tumor location, no significant improvement of AUCs was achieved (AUC = 0.86 and 0.81).
Conclusion
The radiomics model derived from pretreatment DTI may have potential in differentiating the EGFR mutation status in glioblastomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Huashan Hospital, Fudan University, Shanghai, PR China.
- Shanghai Institute of Medical Imaging, Shanghai, PR China.
- Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, PR China.
- Center for Shanghai Intelligent Imaging for Critical Brain Diseases Engineering and Technology Research, Shanghai, PR China.
ORCID-Profile: Qiuyue Han, Bo Yin
Förderung
- National Key R&D Program of China
- Youth Program of Special Project for Clinical Research of Shanghai Municipal Health Commission Health industry
Zitieren
APA
Wang, D., Han, Q., Yang, S., Cui, J., Xia, W., Lu, Y., Yin, B., & Geng, D. (2024). A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult IDH1-wild glioblastomas. Acta Radiologica. https://doi.org/10.1177/02841851241265164
Vancouver
Wang D, Han Q, Yang S, Cui J, Xia W, Lu Y, et al. A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult IDH1-wild glioblastomas. Acta Radiologica. 2024. doi:10.1177/02841851241265164
BibTeX
@article{Wang2024,
author = {Wang, Dongdong and Han, Qiuyue and Yang, Shan and Cui, Jin and Xia, Wei and Lu, Yiping and Yin, Bo and Geng, Daoying},
title = {A DTI-based radiomics model for predicting epidermal growth factor receptor (EGFR) amplification in adult IDH1-wild glioblastomas},
journal = {Acta Radiologica},
year = {2024},
doi = {10.1177/02841851241265164}
}
EUVIMED